Efficacy and Safety of Phoenix dactylifera L. Leaf Extract (WartOver®) in the Treatment of Cutaneous Warts: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 2

Clinical improvement and recurrence of warts in the studied groups.

Outcomes
Clinical improvement	Intervention group		Placebo group
	35; CI: 95%		35; CI: 95%
Complete clearance	24 (68.57%); 0.51–0.81		3 (8.57%); 0.02–0.23
Partial clearance	9 (25.71%); 0.14–0.42		2 (5.71%); 0.006–0.19
No response	2 (5.71%); 0.006–0.196		30 (85.71%); 0.70–0.94
	Value	df	Asymptotic significance (2-sided)
Pearson chi-square	45.288	2	<0.001
Likelihood ratio	52.810	2	<0.001
Recurrence rates	Intervention group		Placebo group
Patients with complete clearance	N = 24		N = 3
Number of patients with recurrence	0		3 (8.57%); 0.02–0.23
	Value	df	Asymptotic significance (2-sided)
Pearson chi-square	27	1	<0.001
Likelihood ratio	18.837	1	<0.001